BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37338093)

  • 1. Correlation analysis for alterations of intestinal flora in hepatocellular carcinoma patients: combinatorial detection of
    Xu W; Jiang Y; Tao J; Liu Y; Xia Y; Chen C; Jiang X
    J Med Microbiol; 2023 Jun; 72(6):. PubMed ID: 37338093
    [No Abstract]   [Full Text] [Related]  

  • 2. Intestinal microecology in mice bearing diethylnitrosamine-induced primary hepatocellular carcinoma.
    Zhou W; Zheng Y; Shang J; Wang H; Wang Y; Lu H; Wang X; Sui M
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 51(4):438-453. PubMed ID: 37202098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbial signatures of patients with primary hepatocellular carcinoma and their healthy first-degree relatives.
    Feng J; Wu Y; Dai P; Wang D; Liu L; Chai B
    J Appl Microbiol; 2023 Oct; 134(10):. PubMed ID: 37777841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated microbiome and metabolome analysis reveals the interaction between intestinal flora and serum metabolites as potential biomarkers in hepatocellular carcinoma patients.
    Li X; Yi Y; Wu T; Chen N; Gu X; Xiang L; Jiang Z; Li J; Jin H
    Front Cell Infect Microbiol; 2023; 13():1170748. PubMed ID: 37260707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A different gut microbiome linked to inflammation found in cirrhotic patients with and without hepatocellular carcinoma.
    Piñero F; Vazquez M; Baré P; Rohr C; Mendizabal M; Sciara M; Alonso C; Fay F; Silva M
    Ann Hepatol; 2019; 18(3):480-487. PubMed ID: 31023615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic potential of gut microbiome for early hepatitis B virus-related hepatocellular carcinoma.
    Tang Y; Zhou H; Xiang Y; Cui F
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e167-e175. PubMed ID: 33208683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal flora altered and correlated with interleukin-2/4 in patients with primary immune thrombocytopenia.
    Wang H; Bi H; Yang M; Wang X; Song C; Yang W; Wang Y; Xie D; Li H; Zhou Z
    Hematology; 2023 Dec; 28(1):2277501. PubMed ID: 37921501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spleen-strengthening and liver-draining herbal formula treatment of non-alcoholic fatty liver disease by regulation of intestinal flora in clinical trial.
    Hui D; Liu L; Azami NLB; Song J; Huang Y; Xu W; Wu C; Xie D; Jiang Y; Bian Y; Sun M
    Front Endocrinol (Lausanne); 2022; 13():1107071. PubMed ID: 36743913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation study between changes in intestinal microflora structure and immune indexes in newly treated patients with pulmonary tuberculosis].
    Xie JH; Yu R; Shi GM; Ma XH; Xiao SF; Yi YH; Zhou T; Xiang YG
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Dec; 55(12):1486-1490. PubMed ID: 34963248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on the Characteristics of Intestinal Flora Composition in Gastric Cancer Patients and Healthy People in the Qinghai-Tibet Plateau.
    Zhang Z; Zhu L; Ma Y; Wang B; Ci C; Zhang J; Zhou Y; Dou C; Gu Q; An Y; Lan Y; Zhao J
    Appl Biochem Biotechnol; 2022 Apr; 194(4):1510-1526. PubMed ID: 34792749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiome as a biomarker for predicting early recurrence of HBV-related hepatocellular carcinoma.
    Zheng C; Lu F; Chen B; Yang J; Yu H; Wang D; Xie H; Chen K; Xie Y; Li J; Bo Z; Wang Y; Chen G; Deng T
    Cancer Sci; 2023 Dec; 114(12):4717-4731. PubMed ID: 37778742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of oral and intestinal florae and serum inflammatory factors with pathogenesis of oral cancer.
    Guo N; Zhou LX; Meng N; Shi YP
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11090-11095. PubMed ID: 33215425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome cannot mask the changes of faecal microbiota compositions caused by primary hepatocellular carcinoma.
    Ni J; Fu C; Huang R; Li Z; Li S; Cao P; Zhong K; Ge M; Gao Y
    Lett Appl Microbiol; 2021 Jul; 73(1):73-80. PubMed ID: 33768575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of the dynamic changes in gut microbiota in patients with extremely severe burns by 16S ribosomal RNA high-throughput sequencing technology].
    Pan YY; Fan YF; Li JL; Cui SY; Huang N; Jin GY; Chen C; Zhang C
    Zhonghua Shao Shang Za Zhi; 2020 Dec; 36(12):1159-1166. PubMed ID: 33379852
    [No Abstract]   [Full Text] [Related]  

  • 15. Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients.
    Chung MW; Kim MJ; Won EJ; Lee YJ; Yun YW; Cho SB; Joo YE; Hwang JE; Bae WK; Chung IJ; Shin MG; Shin JH
    World J Gastroenterol; 2021 Nov; 27(42):7340-7349. PubMed ID: 34876793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Modified Xijiao Dihuang Decoction () on Intestinal Flora and Th17/Treg in Rats with Radiation Enteritis.
    Wang YG; Gao Y; Feng J; Dou YQ
    Chin J Integr Med; 2021 Mar; 27(3):198-205. PubMed ID: 32240475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal flora alterations in patients with early chronic kidney disease: a case-control study among the Han population in southwestern China.
    Hu Q; Wu K; Pan W; Zeng Y; Hu K; Chen D; Huang X; Zhang Q
    J Int Med Res; 2020 Jun; 48(6):300060520926033. PubMed ID: 32495708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection and analysis of intestinal flora diversity in patients with complex anal fistula].
    Qiu JM; Yang GG; Wang D; Chen JM; Shen Z; Shao SX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Sep; 25(9):792-797. PubMed ID: 36117370
    [No Abstract]   [Full Text] [Related]  

  • 19. [Characteristics of intestinal flora in patients with primary Sjögren syndrome].
    Wang X; Wang J; Guo W; Zhou Y; Sun C; Li Z; Chen L; Pan X
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jul; 40(7):949-957. PubMed ID: 32895147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte-macrophage colony-stimulating factor protects mice against hepatocellular carcinoma by ameliorating intestinal dysbiosis and attenuating inflammation.
    Wu YN; Zhang L; Chen T; Li X; He LH; Liu GX
    World J Gastroenterol; 2020 Sep; 26(36):5420-5436. PubMed ID: 33024394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.